Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 143

1. Kokate CK, Purohit AP, Gokhale SB. Textbook of Pharmacognosy. 14th

ed. Pune:

Nirali Prakashan. 2000: 1-4.

2. Siddhiqui T, Ahmed J. Vitamin C content of Indian medicinal plants – A literature

review. Indian Drugs. 1985; 23(2): 72-84.

3. Ramarao AV, Gurjar MK. Drugs from plant resources, an overview. Pharma Times.

1990; 22(5): 19-21.

4. Handa SS. Plants as drugs. The Eastern Pharmacist. 1991; XXXIV (397): 79-85

5. Atindehou KK, Schmid C, Brun R., Koné MW, Traore D. Antitrypanosomal and

antiplasmodial activity of medicinal plants from Côte d’Ivoire. J Ethnopharmacol.

2004; 90: 221–27.

6. Matu EN, Van Staden J. Antibacterial and anti-inflammatory activities of some

plants used for medicinal purposes in Kenya. J Ethnopharmacol. 2003; 87: 35–41.

7. Mukherjee PK, Sahu M, Suresh B. Indian Herbal Medicines. The Eastern

Pharmacist. 1998; XLI (484): 21-3.

8. Naik SR. Plant Derived Drugs. The Eastern Pharmacist 1986; 36: 35-9.

9. Srimal, Shukla R. Recent Research in India on Indigenous Plants for the treatment of

hypertension. Indian Drugs 1987; 24(9): 419-22.

10. Butler MS. The role of natural products chemistry in drug discovery. J Nat Prod.

2004; 67: 2141-53.

11. Pandey MM, Rastogi S, Rawat AKS. Indian herbal drug for general healthcare: An

overview. Internet J Alter Med. 2008; 6: 1-2.

12. Gupta AK, Chitme HR. Herbal medicine for health. The Eastern Pharmacist. 2000;

XLIII (512): 41-5.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 144

13. Dobriyal RM, Narayana BA. Ayurvedic herbal raw material. The Eastern

Pharmacist. 1998; XLI (484): 31-5.

14. envis.frlht.org/Indian-medicinal-plants-database.php (Accessed on 13th March 2012

at 5:30 PM)

15. Mukherjee PK. Ethnopharmacology in Drug Development. GMP for Botanicals.

New Delhi: Business Horizons. 2003; 99-112.

16. Patwardhan B. Ayurveda: The designer medicine: A review of ethnopharmacology

and bioprospecting research. Indian Drugs. 2000; 37(5): 213-27.

17. Bhattacharjee SK. Introduction-Medicinal Herbs and Flowers. Aavishkar Publishers.

2006; 6-9.

18. https//www.wikipedia.com/pain. (Accessed on 25th

February 2010 at 10:45 AM).

19. Lynn B. Cutaneous Nociceptors. In: Winlow W, Holden AV. The neurobiology of

pain: Symposium of the Northern Neurobiology Group, held at Leeds on 18 April

1983. Manchester: Manchester University Press; 1984; 106.

20. Bernston GG, Cacioppo JT. The neuroevolution of motivation. In: Gardner WL,

Shah JY. Handbook of Motivation Science. New York: The Guilford Press; 2007;

191.

21. Merskey H, Bogduk N. Classification of Chronic Pain. 2nd

ed. Seattle: International

Association for the Study of Pain; 1994; 3-4.

22. Woolf CJ. What is this thing called pain?. J Clin Investigation. 2010; 120 (11):

3742–44.

23. Axelrod YK, Diringer MN. Temperature management in acute neurologic disorders.

Neurol Clin. 2008; 26 (2): 585–603.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 145

24. Karakitsos D, Karabinis A. Hypothermia therapy after traumatic brain injury in

children. N Engl J Med. 2008; 359(11): 1179–80.

25. Kelley KW, Bluthé RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard

SR. Cytokine-induced sickness behavior. Brain, Behavior, and Immunity. 2003;

17(1): S112-8.

26. Khan A, Baki MA, Abdul M, Alim Al-Bari, Hasan S. Antipyretic activity of roots of

Laportea crenulata Gaud in Rabbit. Res J Med Medical Sci. 2007; 2(2): 58-61.

27. Levander SM, Forsberg C, Wahren LK. Normal oral, rectal, tympanic and axillary

body temperature in adult men and women: a systematic literature review. Scand J

Caring Sci. 2002; 16(2): 122–8.

28. Cheng L, Ming-liang H, Lars B. Is COX-2 a perpetrator or a protector? Selective

COX-2 inhibitors remain controversial. Acta Pharmacological Sinica, 2002; 26: 926-

3.

29. Borchardt JK. The Beginnings of Drug Therapy: Ancient Egyptian Medicine. Drug

News and Perspectives. 1999; 12: 123-7.

30. Florey HW. General Pathology. 3rd

ed, London: Vol-I, Liyod-Luk Ltd. 1964;21-5.

31. Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ. Acute phase reaction and acute

phase proteins. J Zhejiang Univ Sci B.2005; 6: 1045-56.

32. Cohen J. The immunopathogenesis of sepsis. Nature. 2002; 420: 885-91.

33. Brady, Larner, Minnoman. Human Pharmacology. 3rd

ed, Toronto: Mosby Harcourt,

1998; 395-408.

34. Beecher HK. A History of Pain Management. The Austr J Pharm. 2001; 82: 952-4.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 146

35. Rang HP, Dale MM, Ritter JM. Pharmacology. 4th ed, London: Churchill

Livingstone, 1999; 236-7.

36. Chikanza IC, Jawed S, Naughton D, Blake DR. Why do we need new treatments for

rheumatoid arthritis. J Pharm Pharmacol. 1998; 50: 357-9.

37. Cotran RS, Kumar V, Collins. Robinson's Pathological Basis of Disease. 6th ed.

Harcourt Asia Pvt. Ltd. 1999; 432-45.

38. Eric GB, Lawrence JL. The Textbook of Therapeutics: Drug and Disease

Management. 16th ed, Baltimore: Williams and Wilkins Company. 1996; 579-95.

39. Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis. 2002; 61: 84-6.

40. Grassi W, De AR, Lamanna G, Cervinic. The clinical features of rheumatoid

arthritis. Eur J Radiol. 1998; 27: 18-24.

41. http://www.medicinenet.com/script/main/art.asp?articlekey=92881 (Accessed on

20th January 2010 at 11:31 AM).

42. Farnsworth NR. A computerized database for medicinal plants. The Eastern

Pharmacist 1985; 326(28): 53-5.

43. Chambers HF. General Principles of Chemotherapy. The Pharmacological Basis of

Therapeutics. 11th ed, New York: Goodman and Gillman. 2004; 1095-124.

44. Khosravi A, Behzadi A; Evaluation of the antibacterial activity of the seed hull of

Quercus barantii on some gram-negative bacteria. Pak J Med Sci. 2006; 22:429-32.

45. http://www.wrongdiagnosis.com/b/bacterial_diseases/ intro .htm. (Accessed on 10th

September 2010 at 4:43 PM).

46. Alanis AL. Resistance to antibiotics: Are we in the post-antibiotic era? Arch Med

Res. 2005; 36: 697–05.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 147

47. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over

the period 1981–2002. J Nat Prod. 2003; 66: 1022–37.

48. Solanki R. Some medicinal plants with antibacterial activity. Pharmacie Globale Int

J Comprehen Pharm. 2010; 4(1): 1-4.

49. Singh MK, Nagori K, Tripathi DK. Potential analgesic & anti-pyretic herbal drugs:

a comparative review of marketed products. Int J Phytomed. 2010; 2: 197-209.

50. Shah BN, Nayak BS, Seth AK, Jalalpure SS, Patel KN, Patel MA, Mishra AD.

Search for medicinal plants as a source of anti-inflammatory and anti-arthritic agents

- A review. Pharmacognosy Magazine.2006; 2(6): 77-86.

51. Parmar N, Rawal M. Medicinal plants used as antimicrobial agents: A review. Int

Res J Pharm. 2012; 3(1): 31-40.

52. Sharma JP, Srivastava A, Thakur SP, Barpete PK, Singh S. Herbal medicine as

antipyretic: A comprehensive review. Int J Pharm Life Sci. 2010; 1(1): 18-22.

53. Hajhashemie. Analgesic and anti-inflammatory activity effects of Rosa damascen

hydroalcoholic extract and its essential oil in animal models. Iranian J Pharm Res.

2010; 9(2): 163-8.

54. Alanis AL. Resistance to antibiotics: Are we in the post-antibiotic era? Arch Med

Res. 2005; 36: 697–05.

55. Shukla S, Mehta A, Mehta P, Vyas SP, Bajpai VK. Studies on anti-inflammatory,

antipyretic and analgesic properties of Caesalpinia bonducella F. seed oil in

experimental animal models. Food and Chemical Toxicol. 2010; 48: 61-4.

56. Kirtkar KR, Basu BD. Indian Medicinal Plants. Dehradun: Vol-I, International Book

Distributors. 1999:340-43.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 148

57. Nadkarni AK. Indian Materia Medica. Bombay: Vol-I. Popular Prakashan Pvt. Ltd.

1998; 629-30.

58. Chaterjee AS, Treatise of Indian Medicinal Plants. New Delhi: Vol-II, NISCAIR,

1995; 188-190.

59. Varier’s PS. Indian Medicinal Plants. Chennai: Vol-V, Orient Longaman ltd. 1997;

281.

60. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. New Delhi:

Vol-III, CSIR, 1956; 243.

61. Anonymous. The Wealth of India. Dictionary of Indian Raw Materials and Industrial

Products. New Delhi: Vol-VI, Publication and Information Directorate, CSIR, 1995;

223-25.

62. Viswanatha GL, Hanumantappa S, Krishnadas N, Rangappa S. Antidiarrheal effect

of fractions from stem bark of Thespesia populnea in rodents: Possible antimotility

and antisecretory mechanisms. Asian Pac J Trop Med. 2011; 4(6): 451-6.

63. Saxena PK, Mishra SB, Das T Mourya A. Phytochemical investigation and

antimicrobial activity of stem bark extracts of Thespesia populnea. Inter J Pharma

Res. 2010; 1(1): 24-9.

64. Belhekar SN, Pandhare RB Gawade SP. Antihyperglycemic Effect of Thespesia

Populnea (L) seed extracts in normal and alloxan induced diabetic rats. J Pharm Res.

2009; 2(12): 1860-3.

65. Yuvaraj P, Subramoniam A. Hepatoprotective property of Thespesia populnea

against carbon tetrachloride induced liver damage in rats. J Basic Clin Physiol

Pharmacol. 2009; 20(2): 169-77.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 149

66. Saravanakumar A, Venkateshwaran K, Vanitha J, Ganesh M, Vasudevan M,

Sivakumar T. Evaluation of antibacterial activity, phenol and flavonoid contents of

Thespesia populnea flower extracts. Pak J Pharm Sci. 2009; 22(3): 282-6.

67. Sarvanakumar A, Venkateshwan K, Vanitha J, Saravan VS, Ganesh M, Vasudevan

M, Sivakumar T. Synergistic activity of methanolic extract of Thespesia populnea

flowers with oxytetracyclines. Bang J Pharmacol. 2009; 4:13-6.

68. Parthasathy R, Ilavarasan R. Antidiabetic activity of Thespesia Populnea bark and

leaf extract against streptozotocin induced diabetic rats. Int J PharmTech Res. 2009;

1(4): 1069-72.

69. Shrivastav S, Sindhu RK, Kumar S, Kumar P. Anti-psoriatic and phytochemical

evaluation of Thespesiapopulnea bark extracts. Int J Pharm Pharmaceut Sci. 2009:

1(1); 176-85.

70. Viswanatha GL, Shyalaja H, Srinath R, Nandkumar K, Ramesh C. Preliminary

phytochemical studies and antimicrobial activity of stem bark of Thespesia

populnea. Pharmacologyonline. 2008; 2: 467-70.

71. Boonsri S, Karalai C, Ponglimanont C, Chantrapromma S, Kanjana OA.Cytotoxic

and antibacterial sesquiterpenes from Thespesia populnea. J Nat Prod. 2008; 71(7):

1173-7.

72. Kumar GS, Jayaveera KN, Ashok Kumar CK, Umachigi PS, Vrushabendra BM,

Kishorekumar DV. Antimicrobial effects of Indian medicinal plants against acne-

inducing bacteria. Trop J Pharma Res. 2007; 6(2): 717-23.

73. Vasudevan M, Parle M. Memory-enhancing activity of Thespesia populnea in rats.

Pharm Bio. 2007; 45(4): 267-73.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 150

74. Chantrapromma S, Boonsri S, Fun HK, Karalai C.7-Hydroxy-3,6,9-trimethyl-

2,3,5,6-tetrahydronaphtho [1,8-b,c] pyran-4,8-dione. Acta Crystallographica Section

E: Structure Reports Online. 2007; 63(5): 2749-50.

75. Fun HK, Boonsri S, Chantrapromma S, Boonnak N, Karalai C. 3,6,9-Trimethyl-2,3-

dihydro-benzo[de]chromene-7,8-dione. Acta Crystallographica Section E:Structure

Reports Online. 2007; 63(5): 2127-9.

76. Viswanatha GL, Srinath R, Nandakumar K, Shylaja H, Lakshman K. Antidiarrheal

activity of alcoholic and aqueous extracts of stem bark of Thespesia populnea in

rodents. Pharmacologyonline. 2007; 3: 222-30.

77. Boonsri S, Chantrapromma S, Fun HK, Karalai C. 1,5,8-Trimethyl-1,2-dihydro-

naphtho[2,1-b]furan-6,7-dione. Acta Crystallographica Section E: Structure Reports

Online. 2007; 63(12): 4901.

78. Shivakumar H, Prakash T, Rao RN, Swamy BHMJ. Nadappa AN. Wound healing

activity of the leaves of Thespesia populnea. J Nat Rem. 2007; 7(1): 120-24.

79. Anandjiwala S, Bagul MS, Srinivasa H, Kalola J, Rajani M. Antioxidant activity of

stem bark of Thespesia populnea Soland ex Corr. J Nat Rem. 2007; 7(1): 135-41.

80. Vasudevan M, Gunnam KK, Parle M. Antinociceptive and anti-inflammatory effects

of Thespesia populnea bark extract. J Ethnopharmacol. 2007; 109: 264-70.

81. Vasudevan M, Parle M. Pharmacological actions of Thespesia populnea relevant to

Alzheimir’s disease. Phytomedocine. 2006; 13(9-10): 677-87.

82. Satyanarayana T, Sarita T, Balaji M, Ramesh A, Boini MK. Antihyperglycemic and

hypoglycemic effect of Thespesia populnea fruit in normal and alloxan-induced

diabetes in rabbits. Saudi Pharma J. 2004; 12(2-3): 107-11.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 151

83. Ghosh K, Bhattacharya TK. Preliminary study on the antiimplantation activity of

compounds from the extracts of seeds of Thespesia populnea. Indian J Pharmacol

2004; 36(5): 288-91.

84. Puckhaber LS, Stipanovic RD. Thespesenone and dehydrooxoperezinone-6-methyl

ether, new sesquiterpene quinones from Thespesia populnea. J Nat Prod. 2004;

67(9): 1571-3.

85. Krishnamoorthy P, Vaithinathan S. Effect of the extract of Thespesia populnea

leaves on mice testis. J Environmental Biol. 2003; 24(3): 327-30.

86. Ilavarasan R, Vasudevan M, Anbazhagan S, Venkatraman S. Antioxidant activity of

Thespesia populnea bark extracts against carbon tetrachloride-induced liver injury in

rats. J Ethanopharmacol. 2003; 87:227-30.

87. Ilavarasan R, Vasudevan M, Anbazhagan S, Venkatraman S, Sridhar SK.

Hepatoprotective activity of Thespesia populnea bark extracts against CCl4 induced

liver toxicity in rats. Nat Prod Sci. 2003; 9(2):82-6.

88. Jayakumari S, Rajkumar M, Joanofarc J, Rao SG, Sadish KS, Umadevi SK.

Hypoglycemic, antidiabetic and antiulcer screening of Thespesia populnea Linn. Nat

Prod Sci. 2003; 9(3): 167-9.

89. Nagappa AN, Cheriyan B. Wound healing activity of the aqueous extract of

Thespesia populnea fruit. Fitoterapia. 2001; 72(5): 503-06.

90. Kavimani S, Ilango R, Karpagama S, Suryaprabha A, Jaykar B. Antisteroidogenic

activity of floral extract of Thespesia populnea Corr. in mouce. Indian J Exp Biol.

1999; 37(12): 1241-2.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 152

91. Milbrodt M, König WA, Hausen BM.7-hydroxy-2,3,5,6-tetrahydro-3,6,9-Tri

methylnaphtho [1,8-B,C] pyran-4,8- dione from Thespesia populnea. Phytochem.

1997; 45(7): 1523-5.

92. Shirwaikar A, Kumar AV, Krishnanand BR, Sreenivasan KK. Chemical

investigation and antihepatotoxic activity of Thespesia populnea. Inter J Pharmacog.

1995; 33(4): 305-10.

93. Waller DP, Bunyapraphatsara N, Martin A, Vournazos CJ, Ahmed MS, Soejarto

DD, Cordell GA, Malone JP. Effect of (+)-gossypol on fertility in male hamsters. J

Androl. 1983; 4(4): 276-9.

94. Chaterjee AS, Treatise of Indian Medicinal Plants. New Delhi: Vol-III, NISCAIR,

CSIR, 2003; 12-13.

95. Rastogi RP. Compendium of Indian Medicinal Plants. New Delhi: Vol-IV,

Publication and Information Directorate, CSIR, 1989; 171.

96. Varier’s PS. Indian Medicinal Plants. Chennai: Vol-II, Orient Longaman ltd. 1997;

21.

97. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. New Delhi:

Vol-III, CSIR, 1956; 56.

98. Anonymous. The Wealth of India. Dictionary of Indian Raw Materials and Industrial

Products. New Delhi: Vol-VI, Publication and Information Directorate, CSIR, 1995;

223-25.

99. Bairwa NK, Sethiya NK, Mishra SH. Protective effect of stem bark of Ceiba

pentandra linn. against paracetamol-induced hepatotoxicity in rats. Pharmacog Res.

2010; 2(1): 26-30.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 153

100. Sarkiyayi S, Ibrahim S, Abubakar MS. Toxicological studies of Ceiba pentandra

Linn. Afr J Biochem Res. 2009; 3(7): 279-81.

101. Nwachukwu IN, Allison LN, Chinakwe EC, Nwadirao P. Studies on the effects

Cymbopogon citratus, Ceiba pentandra and Loranthus bengwelensis extracts on

species of dermatophytes. J Am Sci. 2008; 4(4): 52-63.

102. Mpiana PT, Tshibangu DS, Shetonde OM, Ngbolua KN. In vitro antidrepanocytary

activity (antisickle cell anaemia) of some congolese plants. Phytomedicine. 2007; 14

(2-3): 192-5.

103. Basu R. Sacred groves as indicators in ethno-medicinal plants conservation and

biodiversity monitoring. Advances in Plant Sciences 2007; 20(20): 547-50.

104. Ibara JR, Elion-Itou RDG, Etou-Ossebi R, Ouamba JM, Diate WM, Abena AA.

Ethnobotanical survey of presumed anti-ulcer congolese medicinal plants. Phytother.

2007; 5: 118-20.

105. Bizimana N, Tietjen U, Zessin KH, Diallo D, Djibril C, Melzig MF, Clausen PH.

Evaluation of medicinal plants from Mali for their in vitro and in vivo trypanocidal

activity J Ethnopharmacol. 2006; 103(3): 350-56.

106. Dzeufiet PD, Tedong L, Asongalem EA, Dimo T, Sokeng SD, Kamtchouing P.

Hypoglycaemic effect of methylene chloride/methanol root extract of Ceiba

pentandra in normal and diabetic rats. Indian J Pharmacol. 2006; 38:194-7.

107. Narahari D, Asha Rajni R. Chemical composition and nutritive value of kapok seed

meal for broiler chickens Br Poult Sci. 2003; 44(3): 505-9.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 154

108. Ladeji O, Omekarah. Hypoglycaemic properties of aqueous bark extract of Ceiba

pentandra in streptozotocin-induced diabetic rats J Ethnopharmacol. 2003; 84(3):

139-42.

109. Nam NH, Kim HM, Bae KH, Ahn BZ. Inhibitory effects of Vietnamese medicinal

plants on tube-like formation of human umbilical venous cells. Phytother Res. 2003;

17(2): 107-11.

110. Kishore PH, Reddy MVB, Gunasekar D, Caux C, Bodo B. A new naphthoquinone

from Ceiba pentandra. J Asian Nat Prod Res. 2003; 5(3): 227-30.

111. Kanedan UH,Kawanishi K, MoriyasuM. A New isoflavone glycoside from Ceiba

pentandra (L.). Chem Pharm Bull. 2002; 50(3): 403-4.

112. Ngounou FN, Meli AL. New isoflavones from Ceiba pentandra Phytochem. 2000;

54: 107-10.

113. Noreen Y, Seedi EL, Perera P, Bohlin L. Two new isoflavones from Ceiba

pentandra and their effect on cyclooxygenase-catalyzed prostglydin biosynthesis. J

Nat Prod. 1998; 61(1): 8-12.

114. Gowda DC, Shantha RT, Anjaneyalu YV. Structure of water-soluble acidic

polysaccharides isolated from the bark of Ceiba pentandra var. indica. Carbohydrate

Res.1989; 191: 321-2.

115. Kaimal TNB, Gollamudi L. Changes in lipids of maturing Ceiba pentandra seeds.

Phytochem. 1972; 11(5): 1617-22.

116. Kaimal TNB, Gollamudi L. Fatty acid compositions of lipids isolated from different

parts of Ceiba pentandra, Sterculia foetida and Hydnocarpus wightiana. Phytochem

1970; 9(10): 2225-9.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 155

117. Khandelwal KR. Practical Pharmacognosy, Technique and Experiments. 9th ed.

Pune: Nirali Prakashan; 2002; 82-97.

118. Indian Pharmacopoeia. Vol. II, Delhi: Controller of Publication. 1996; A3:38.

119. Indian Pharmacopoeia. Vol. II, Delhi: Controller of Publication. 1996; A3:38

120. Kokate CK. Practical Pharmacognosy. New Delhi: Vallabh Prakashan. 1994; 135.

121. Harborne JB. Methods of extraction and isolation. 2nd ed. London: Chapman &

Hall; 1988; 4-7.

122. Indian Pharmacopoeia, Vol. I, Delhi: Controller of Publication. 1996; 209-10.

123. Bailey AV, Pittman RA, Magne FC, Skau EL. Methods for determination of

cyclopropenoid fatty acids: a spectrophotometric method for cotton seed oil based

upon the Halphen test reaction. J Am Oil Chem Soc. 1965; 42: 422-4.

124. Lakshminarayana G. Applicability of the turbidity test for castor oil to some other

hydroxy and epoxy fatty compounds. J Am Oil Chem Soc. 1968; 45: 523-4.

125. Rebatock MC, Crooka HM, Barta QR. Official and Tentative Methods of American

oil Chemists Scociety. 3rd

ed. Champaign, 11: AOCS.1997; 134-9.

126. Fiorit JM, Sim RJ. A rapid micro-method for the separation, identification and

estimation of purine bases; caffeine, theobromine and theophylline. J Chromatogr.

1968; 32: 76.

127. Khandelwal KR. Practical Pharmacognosy, Techniques and Experiments. 9th ed.

Pune: Nirali Prakashan. 2002; 149-56.

128. Kokate CK. Practical Pharmacognosy. New Delhi: Vallabh Prakashan. 1994; 135-

47.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 156

129. Al-Ashaal HA, Farghaly AA, Abd El Aziz MM, Ali MA. Phytochemical

investigation and medicinal evaluation of fixed oil of Balanites aegyptiaca fruits

(Balantiaceae). J Ethnopharmacol. 2010; 127; 495-501.

130. Khoobchandani M, Ojeswi BK, Ganesh N, Srivastava MM, Gabbanini S, Metra R,

Iori R, Valgimigli L. Antimicrobial properties and analytical profile of traditional

Eruca sativa seed oil: comparison with various aerial and root plant extracts. Food

Chem. 2010; 120: 217-24.

131. OECD/OCDE, Guidelines for the testing of chemicals. Revised draft guidelines 423:

Acute Oral Toxicity – Acute Toxic Class Method, Revised Document. 2000 Oct.

132. Vogel HG. Drug Discovery and Evaluation, Pharmacological Assays. 2nd

ed. Berlin.

Springer. 2002; 697.

133. Mateo CCS,. Bonkanka CX, Hern´andez-PM, Rabanal RM. Evaluation of the

analgesic and topical anti-inflammatory effects of Hypericum reflexum L. fil. J

ethnopharmacol. 2006; 107: 1–6.

134. Bose A, Mondal S, Gupta JK, Ghosh T, Dash GK, Si S. Analgesic, anti-

inflammatory and antipyretic activities of the ethanolic extract and its fractions of

Cleome rutidosperma. Fitoter. 2007; 78: 515–20.

135. Gupta M, Mazumder UK, Sambath RK, Gomathi P, Rajeshwar Y, Kakoti BB,

Selven VT. Anti-inflammatory, analgesic and antipyretic effects of methanol extract

from Bauhinia racemosa stem bark in animal models. J Ethnopharmacol. 2005; 98:

267–73.

136. Begum S. Saxena B, Goyal M, Ranjan R, Joshi VB, Rao CV, Krishnamurhty S,

Sahai M. Study of anti-inflammatory, analgesic and antipyretic activities of seeds of

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 157

Hyoscyamus niger and isolation of a new coumarinolignan. Fitotera. 2010; 81: 178-

84.

137. Panthong A, Norkaew P, Reutrakul V. Anti-inflammatory, analgesic and antipyretic

activities of the extract of gamboges from Garcinia hanburyi Hook f. J

Ethnopharmacol. 2007; 111: 335-40.

138. Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella

sativa. J Ethnopharmacol. 2001; 76: 45-8.

139. Lee J, Kim KA, Jeong SH, Lee SG, Park HJ. Anti-inflammatory, anti-nociceptive,

and anti-psychiatric effects by the rhizomes of Alpinia officinarum on complete

Freund’s adjuvant-induced arthritis in rats. J Ethnopharmacol. 2009; 126: 258-64.

140. Vogel HG. Drug Discovery and Evaluation, Pharmacological assays. 2nd

ed. Berlin.

Springer. 2002: 802-05.

141. Kulkarni SK. Handbook of Experimental Pharmacology .2nd

ed. Mumbai: Vallabh

Prakashan, 1993; 179-89.

142. Chatwal GR, Anand SK. Instrumental methods of chemical analysis. 7th

ed.

Himalaya Publishing House. 1992: 588-98.

143. Wagner H, Baldet S, Zagainski EM. Plant Drug Analysis- A TLC. Germany: Atlas

Springer-Verlag Berlin Heidelberg; 1994; 163-9.

144. Dieter Janchen. Lamag Bibliography Service, Thin Layer Chromatography,

CAMAG, Switzerland. No.79. 1997.

145. Skoog, Holler, Nieman. Principles of Instrumental Analysis. 5th ed. A Harcourt

Publishers International Company; 2001; 380-401.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 158

146. Khoobchandani M, Ojeswi BK, Ganesh N, Srivastava MM,Gabbanini S, Metra R,

Iori R, Valgimigli L. Antimicrobial properties and analytical profile of traditional

Eruca sativa seed oil: comparison with various aerial and root plant extracts. Food

Chem. 2010; 120: 217-24.

147. Saeed MK, Deng Y, Dai R, Li Wei, Yu Y, Iqbal Z. Appraisal of antinociceptive and

anti-inflammatory potential of extract and fractions from the leaves of Torreya

grandis Fort Ex. Lindl. J Ethnopharmacol. 2010; 127: 414-18.

148. Adamonics JA. Chromatographic Analysis of Phamraceuticals. New York: Marcel

Dekker. 1997; 57-72.

149. Eldahshan OA. Isolation and structure elucidation of phenolic compounds of carb

leaves grown in Egypt. Curr Res J Biol Sci. 2011; 3(1): 52-5.

150. Naira N, Karvekar MD. Isolation of phenolic compounds from the methanolic

extract of Tectona grandis. Res J Pharm Bio Chem Sci. 2010; 1(2): 221-5.

151. Chen Z, Liu YM, Yang S, Song BA. Studies on the chemical constituents and

anticancer activity of Saxifraga stolonifera (L) Meeb. Bioorg Med Chem. 2008; 16:

1337-44.

152. Curran JP, Al-Salihi FL. Neonatal staphylococcal scalded skin syndrome: Massive

outbreak due to an unusual phage type. Pediatrics. 1980; 66: 285–90.

153. List PH, Schmidt PC. Pharmaceutical Technology, Heyden & Son, London, 1989;

51-6.

154. Sader HS, Jones RN, Silva JB. Skin and soft tissue infections in latin american

medical centers: four-year assessment of the pathogen frequency and antimicrobial

susceptibility patterns. Diagn Microbiol Infect Dis.2002; 44(3): 281-8.

Chapter 8 BIBLIOGRAPHY

KLE uNivErsity’s COLLEgE Of PharMaCy, BELgauM 159

155. Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob

Agents. 2005; 26(5): 343-56.

156. Du H, Wang Y, Hao X, Li C, Peng Y, Wang J, Liu H, Zhou L. Antimicrobial

phenolic compounds from Anabasis aphylla L. Nat Prod Commun. 2009; 4(3): 385-

8.

157. Ogonowski AA, May WS, Moor AB, Barrat LI, Bryant CL, Pollock SH. Anti-

inflammatory and analgesic activity of an inhibitor of Neuropeptide amidiation. J

Pho Exp Ther. 1997; 280: 846-53.

158. Nayer V, Singh S, Gupta YK. Evaluation of the disease modifying activity of

Colchicum leuteum Baker. In experimental arthritis. J ethnopharmacol. 2010; 127: 1-

21.

159. Patil KR, Patil CR, Jadhav RB. Anti-arthritic activity of bartogenic acid isolated

from fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evidence Based

Complementary and Alternative Medicines. 2009; 1–7.

160. Patil KS, Suuryavanshi J. Effect of Celastrus paniculatus Willd. seed on adjuvant

induced arthritis in rats. Pharmacog Mag. 2007; 3: 177-81.

161. Kamboj A, Saluja AK. Isolation of stigmasterol and β-sitostrol from petroleum

ether extracts of aerial parts of Ageratum conyzoides. Int J Pharm Pharm Sci. 2011;

3(1): 94-6.